<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A quantitative in vivo assay for evaluating the tumorigenicity of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cell lines in <z:mp ids='MP_0003815'>nude</z:mp> mice is described </plain></SENT>
<SENT sid="1" pm="."><plain>It is based on the dose-response kinetics of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines in pre-irradiated (480 rad) <z:mp ids='MP_0003815'>nude</z:mp> mice following the s.c. injection of 4 different cell doses </plain></SENT>
<SENT sid="2" pm="."><plain>This model system was used to estimate the xenografting potential of 26 BL cell lines derived from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> patients of different geographic and ethnic origins, as well as lymphoblastoid cell lines (LCLs) established by Epstein-Barr virus (EBV) immortalization of <z:mpath ids='MPATH_458'>normal</z:mpath> B lymphocytes </plain></SENT>
<SENT sid="3" pm="."><plain>The results indicate that most <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines are tumorigenic, but LCLs fail to produce progressively growing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> in <z:mp ids='MP_0003815'>nude</z:mp> mice </plain></SENT>
<SENT sid="4" pm="."><plain>However, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines revealed individual degrees of tumorigenicity and accordingly could be divided into 4 groups with high, moderate, low or no tumorigenicity </plain></SENT>
<SENT sid="5" pm="."><plain>Preliminary attempts to correlate the xenografting phenotype of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> lines with other characteristics indicate that: (1) the aberrations of chromosome 1 are more often encountered in cell lines with high and moderate tumorigenicity; (2) EBV-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> lines do not reveal a higher tumorigenic phenotype in comparison with EBV-negative ones; (3) cell lines carrying translocations t(8;22) and t(2;8) might fall more frequently in the group of lines with high and moderate tumorigenicity; and (4) when LCLs grow in nu/nu mice, rejection always occurs and is associated with massive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>These findings suggest that the tumorigenicity of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cell lines in immunosuppressed animals is not related with EBV, but with certain chromosomal abnormalities (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>-specific and non-specific) indicating that this in vivo model system can be instrumental for the identification of other factors or stages involved in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> development </plain></SENT>
</text></document>